The Collaborative Ocular Tuberculosis Study (COTS) calculator-a consensus-based decision tool for initiating antitubercular therapy in ocular tuberculosis.
Rupesh V AgrawalZhang LudiBjorn Kaijun BetzlerIlaria TestiSarakshi MahajanAndrés Rousselot AscarzaJohn H KempenJustine R SmithPeter McCluskeyQuan Dong NguyenCarlos PavesioVishali GuptaPublished in: Eye (London, England) (2022)
The COTS Calculator is an efficient, low-cost, evidence and experience-based clinical tool to guide ATT initiation. While it holds substantial promise in improving standard-of-care for ocular-TB patients, future validation studies can help to as certain its clinical utility and reliability.
Keyphrases
- low cost
- mycobacterium tuberculosis
- end stage renal disease
- ejection fraction
- newly diagnosed
- healthcare
- chronic kidney disease
- pulmonary tuberculosis
- prognostic factors
- hiv aids
- optic nerve
- machine learning
- current status
- emergency department
- adverse drug
- big data
- human immunodeficiency virus
- mesenchymal stem cells
- decision making
- health insurance
- electronic health record
- antiretroviral therapy
- patient reported
- hiv infected
- replacement therapy